Event
Neuralink opens recruitment for first-in-human PRIME Study
Key points
- Neuralink opened recruitment for its first-in-human PRIME Study at its first hospital site.
- The study targets people with quadriplegia due to cervical spinal cord injury or amyotrophic lateral sclerosis.
- Neuralink described the study as evaluating the investigational N1 Implant and R1 Robot system.
Company context
Neuralink is a neurotechnology company developing implantable brain-computer interfaces for people with unmet medical needs, beginning with device control for people with paralysis. Its system combines the N1 Implant, external software, wireless communication, and the R1 surgical robot used to place ultra-fine electrode threads in the brain.
Context
- Company
- Neuralink
- Segment
- Healthcare
- Event type
- Regulatory
- Geography
- Fremont · United States